1. Home
  2. RZLT vs CANG Comparison

RZLT vs CANG Comparison

Compare RZLT & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • CANG
  • Stock Information
  • Founded
  • RZLT 2010
  • CANG 2010
  • Country
  • RZLT United States
  • CANG Hong Kong
  • Employees
  • RZLT N/A
  • CANG N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • CANG Computer Software: Prepackaged Software
  • Sector
  • RZLT Health Care
  • CANG Technology
  • Exchange
  • RZLT Nasdaq
  • CANG Nasdaq
  • Market Cap
  • RZLT 713.4M
  • CANG 811.9M
  • IPO Year
  • RZLT N/A
  • CANG 2018
  • Fundamental
  • Price
  • RZLT $8.77
  • CANG $4.66
  • Analyst Decision
  • RZLT Strong Buy
  • CANG Strong Buy
  • Analyst Count
  • RZLT 6
  • CANG 1
  • Target Price
  • RZLT $14.50
  • CANG $8.00
  • AVG Volume (30 Days)
  • RZLT 1.6M
  • CANG 530.3K
  • Earning Date
  • RZLT 11-06-2025
  • CANG 11-03-2025
  • Dividend Yield
  • RZLT N/A
  • CANG N/A
  • EPS Growth
  • RZLT N/A
  • CANG N/A
  • EPS
  • RZLT N/A
  • CANG N/A
  • Revenue
  • RZLT N/A
  • CANG $398,195,540.00
  • Revenue This Year
  • RZLT N/A
  • CANG $514.68
  • Revenue Next Year
  • RZLT N/A
  • CANG $18.40
  • P/E Ratio
  • RZLT N/A
  • CANG N/A
  • Revenue Growth
  • RZLT N/A
  • CANG 380.74
  • 52 Week Low
  • RZLT $2.22
  • CANG $1.55
  • 52 Week High
  • RZLT $9.72
  • CANG $9.66
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 59.75
  • CANG 48.49
  • Support Level
  • RZLT $8.72
  • CANG $4.47
  • Resistance Level
  • RZLT $9.72
  • CANG $4.92
  • Average True Range (ATR)
  • RZLT 0.55
  • CANG 0.24
  • MACD
  • RZLT -0.07
  • CANG 0.04
  • Stochastic Oscillator
  • RZLT 61.35
  • CANG 58.59

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About CANG Cango Inc. each representing two (2)

Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in the bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and associated businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives the majority of its revenue from the bitcoin mining business.

Share on Social Networks: